UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Use of Transcutaneous Oximetry to Predict Healing Complications of Lower Limb Amputations: A Systematic Review and Meta-analysis

European journal of vascular and endovascular surgery, 2012-03, Vol.43 (3), p.329-336

2012

Volltextzugriff (PDF)

Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials

European heart journal, 2008-11, Vol.29 (21), p.2592-2600

2008

Volltextzugriff (PDF)

Systematic review: glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato‐Biliary Group systematic review with meta‐analyses and trial sequential analyses of randomized clinical trials

Alimentary pharmacology & therapeutics, 2008-06, Vol.27 (12), p.1167-1178

2008

Volltextzugriff (PDF)

FRI0431 Why the findings of published rheumatoid arthritis multiple treatment comparisons are so different – an overview of recurrent methodological shortcomings

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.460-460

2013

Volltextzugriff (PDF)

Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta-analysis and trial sequential analysis

British journal of anaesthesia : BJA, 2014-03, Vol.112 (3), p.410-426

2014

Volltextzugriff (PDF)

Network meta-analysis of direct-acting antivirals in combination with peginterferon-ribavirin for previously untreated patients with hepatitis C genotype 1 infection

QJM : An International Journal of Medicine, 2015-04, Vol.108 (4), p.299-306

2015

Volltextzugriff (PDF)

Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analyses

Clinical microbiology and infection, 2014-02, Vol.20 (2), p.114-122

2014

Volltextzugriff (PDF)

CL3 Calibrating Bayesian Multiple Treatment Comparison Meta-Analysis With Multiple Cost-Effectiveness Acceptability Curves

Value in health, 2012-11, Vol.15 (7), p.A286-A286

2012

Volltextzugriff (PDF)

PRM148 Sample Size and Power Considerations in Network Meta-Analysis

Value in health, 2012-11, Vol.15 (7), p.A487-A487

2012

Volltextzugriff (PDF)

Demystifying trial networks and network meta-analysis

BMJ (Online), 2013-05, Vol.346 (may14 2), p.f2914-f2914

2013

Volltextzugriff (PDF)

Factors associated with large increases in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from the bioadvance survey

Value in health, 2014-05, Vol.17 (3), p.A39-A40

2014

Volltextzugriff (PDF)

Cost-effectiveness of golimumab versus infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis

Value in health, 2014-05, Vol.17 (3), p.A38-A38

2014

Volltextzugriff (PDF)

Comparative efficacy and safety of golimumab, infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis: A bayesian indirect treatment comparison meta-analysis

Value in health, 2014-05, Vol.17 (3), p.A35-A35

2014

Volltextzugriff (PDF)

PT22 Consistency Between Comparative Efficacy Estimates from Target Trial Emulations and Their Origin Target Trials: A Meta-Epidemiological Study

Value in health, 2024-06, Vol.27 (6), p.S351-S351

2024

Volltextzugriff (PDF)

PRS52 The Stability of Additive Treatment Effects in Multiple Treatment Comparison Meta-Analysis: a Simulation Study

Value in health, 2012-06, Vol.15 (4), p.A61-A61

2012

Volltextzugriff (PDF)

PMS90 the Influence of ‘Weak Links' on Comparative Treatment Effects in Multiple Treatment Comparison Meta-Analysis: A Simulation Study

Value in health, 2012-06, Vol.15 (4), p.A50-A50

2012

Volltextzugriff (PDF)

PMS85 Why the Findings of Published Rheumatoid Arthritis Multiple Treatment Comparisons are So Different - An Overview of Recurrent Methodological Shortcomings

Value in health, 2012-06, Vol.15 (4), p.A49-A49

2012

Volltextzugriff (PDF)

Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis

QJM : An International Journal of Medicine, 2013-02, Vol.106 (2), p.153-163

2013

Volltextzugriff (PDF)

1141 BOCEPREVIR OR TELAPREVIR IN COMBINATION WITH PEGINTERFERON FOR HEPATITIS C GENOTYPE 1 INFECTION: AN INDIRECT COMPARISON META-REGRESSION ANALYSIS

Journal of hepatology, 2012-04, Vol.56, p.S451-S451

2012

Volltextzugriff (PDF)

Comparative Efficacy and Safety of Empagliflozin with Other Oral Antidiabetic Drugs for the Second Line Treatment of Type 2 Diabetes Mellitus

Value in health, 2014-11, Vol.17 (7), p.A333-A333

2014

Volltextzugriff (PDF)

Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin

Value in health, 2014-11, Vol.17 (7), p.A332-A333

2014

Volltextzugriff (PDF)

Comparative Efficacy and Safety of Empagliflozin with Other Antidiabetic Drugs for the Third Line Treatment of Type 2 Diabetes Mellitus

Value in health, 2014-11, Vol.17 (7), p.A333-A333

2014

Volltextzugriff (PDF)

Easing Decision-Making by Expanding Methods of Multiple Treatment Comparison Meta-Analysis – Incorporating Non-Comparative Studies Via Informative Priors

Value in health, 2013-11, Vol.16 (7), p.A577-A577

2013

Volltextzugriff (PDF)

Modelling drug class effects in bayesian multiple treatment comparison meta-analysis: Applications in early and advanced parkinson's disease

Value in health, 2013-05, Vol.16 (3), p.A26-A26

2013

Volltextzugriff (PDF)

Why are the findings of indirect comparisons of boceprevir and telaprevir for hepatitis C infection different? A methodological review

Value in health, 2013-05, Vol.16 (3), p.A14-A14

2013

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(125)

Sprache

Englisch
(125)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(40)
Humans
(30)
Internal Medicine
(25)
Meta-Analysis
(21)
Male
(14)
Clinical Medicine
(13)
Epidemiology
(13)
Adult
(12)
Female
(11)
Clinical Trials
(9)
Randomized Controlled Trials As Topic
(9)
Medicin Och Hälsovetenskap
(8)
Original Research
(8)
General & Internal Medicine
(7)
Medicine, General & Internal
(7)
Middle Aged
(7)
Public, Environmental & Occupational Health
(7)
Systematic Review
(7)
Aged
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Use of Transcutaneous Oximetry to Predict Healing Complications of Lower Limb Amputations: A Systematic Review and Meta-analysis

Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials

Systematic review: glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato‐Biliary Group systematic review with meta‐analyses and trial sequential analyses of randomized clinical trials

FRI0431 Why the findings of published rheumatoid arthritis multiple treatment comparisons are so different – an overview of recurrent methodological shortcomings

Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta-analysis and trial sequential analysis

Network meta-analysis of direct-acting antivirals in combination with peginterferon-ribavirin for previously untreated patients with hepatitis C genotype 1 infection

Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analyses

CL3 Calibrating Bayesian Multiple Treatment Comparison Meta-Analysis With Multiple Cost-Effectiveness Acceptability Curves

PRM148 Sample Size and Power Considerations in Network Meta-Analysis

Demystifying trial networks and network meta-analysis

Factors associated with large increases in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from the bioadvance survey

Cost-effectiveness of golimumab versus infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis

Comparative efficacy and safety of golimumab, infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis: A bayesian indirect treatment comparison meta-analysis

PT22 Consistency Between Comparative Efficacy Estimates from Target Trial Emulations and Their Origin Target Trials: A Meta-Epidemiological Study

PRS52 The Stability of Additive Treatment Effects in Multiple Treatment Comparison Meta-Analysis: a Simulation Study

PMS90 the Influence of ‘Weak Links' on Comparative Treatment Effects in Multiple Treatment Comparison Meta-Analysis: A Simulation Study

PMS85 Why the Findings of Published Rheumatoid Arthritis Multiple Treatment Comparisons are So Different - An Overview of Recurrent Methodological Shortcomings

Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis

1141 BOCEPREVIR OR TELAPREVIR IN COMBINATION WITH PEGINTERFERON FOR HEPATITIS C GENOTYPE 1 INFECTION: AN INDIRECT COMPARISON META-REGRESSION ANALYSIS

Comparative Efficacy and Safety of Empagliflozin with Other Oral Antidiabetic Drugs for the Second Line Treatment of Type 2 Diabetes Mellitus

Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin

Comparative Efficacy and Safety of Empagliflozin with Other Antidiabetic Drugs for the Third Line Treatment of Type 2 Diabetes Mellitus

Easing Decision-Making by Expanding Methods of Multiple Treatment Comparison Meta-Analysis – Incorporating Non-Comparative Studies Via Informative Priors

Modelling drug class effects in bayesian multiple treatment comparison meta-analysis: Applications in early and advanced parkinson's disease

Why are the findings of indirect comparisons of boceprevir and telaprevir for hepatitis C infection different? A methodological review

Suchergebnisse filtern